title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
McKesson  ( MCK )  Announces Availability of FDA-Cleared Drug for MCL,20230215T140500,https://www.zacks.com/stock/news/2054602/mckesson-mck-announces-availability-of-fda-cleared-drug-for-mcl,MMSI,0.113597,Neutral,0.0
McKesson  ( MCK )  Announces Availability of FDA-Accepted Drug,20221223T181500,https://www.zacks.com/stock/news/2032077/mckesson-mck-announces-availability-of-fda-accepted-drug,MMSI,0.137278,Neutral,0.0
PacBio  ( PACB )  Preliminary Q4 Revenues Boosted by Revio Sales,20240109T154300,https://www.zacks.com/stock/news/2207537/pacbio-pacb-preliminary-q4-revenues-boosted-by-revio-sales,MMSI,0.116348,Neutral,0.0
Merit Medical's  ( MMSI )  New Launch to Expand Its Product Suite,20231012T155500,https://www.zacks.com/stock/news/2165038/merit-medicals-mmsi-new-launch-to-expand-its-product-suite,MMSI,0.12546,Neutral,0.0
PacBio's  ( PACB )  New Tie-Up to Boost Rare Disease Research,20230620T154100,https://www.zacks.com/stock/news/2110759/pacbios-pacb-new-tie-up-to-boost-rare-disease-research,MMSI,0.113062,Neutral,0.0
Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now,20230614T152200,https://www.zacks.com/stock/news/2108381/heres-why-you-should-retain-illumina-ilmn-stock-for-now,MMSI,0.090134,Neutral,0.0
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,20230602T160800,https://www.zacks.com/stock/news/2103412/heres-why-you-should-retain-pacbio-pacb-stock-for-now,MMSI,0.104228,Neutral,0.0
"PacBio  ( PACB )  Tops on Q1 Earnings, Raises FY23 Revenue View",20230503T153500,https://www.zacks.com/stock/news/2089182/pacbio-pacb-tops-on-q1-earnings-raises-fy23-revenue-view,MMSI,0.081414,Neutral,0.048832
PacBio's  ( PACB )  Preliminary Q4 Revenues Dampened by Lower Sales,20230112T172900,https://www.zacks.com/stock/news/2038656/pacbios-pacb-preliminary-q4-revenues-dampened-by-lower-sales,MMSI,0.10607,Neutral,0.0
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,20230104T173400,https://www.zacks.com/stock/news/2035314/heres-why-you-should-retain-pacbio-pacb-stock-for-now,MMSI,0.108222,Neutral,0.0
"PacBio's  ( PACB )  Q3 Earnings Top Estimates, Revenues Lag",20221108T150000,https://www.zacks.com/stock/news/2015503/pacbios-pacb-q3-earnings-top-estimates-revenues-lag,MMSI,0.08197,Neutral,0.0
